4.7 Article

Positive effect of compound amino acid chelated calcium from the shell and skirt of scallop in an ovariectomized rat model of postmenopausal osteoporosis

Journal

JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
Volume 102, Issue 4, Pages 1363-1371

Publisher

WILEY
DOI: 10.1002/jsfa.11468

Keywords

Chlamys farreri processing by-products; compound amino acid chelated calcium; postmenopausal osteoporosis; OPG; RANK; RANKL signaling pathway; Wnt signaling pathway

Funding

  1. People's Livelihoods Science and Technology Project of Qingdao, Shandong Province, China [17-3-3-68-nsh]
  2. Shandong Province Key RD Projects [2016ZDJS06A01]

Ask authors/readers for more resources

The study showed that CAA-Ca promoted bone formation, inhibited bone resorption, and improved bone microstructure by reducing bone resorption, increasing calcium absorption, and promoting bone formation, indicating its potential as a functional food resource for the treatment of postmenopausal osteoporosis.
BACKGROUND Osteoporosis has become an important public health issue with the increase of aging population, and afflicts millions of people worldwide, particularly elderly or postmenopausal women. In the present study, we prepared compound amino acid chelated calcium (CAA-Ca) from processing by-products of Chlamys farreri, and evaluated its effect on postmenopausal osteoporosis with an ovariectomized (OVX) rat model. RESULTS A 60-day treatment of OVX rats with CAA-Ca significantly enhanced the bone mineral density (BMD) and the bone calcium content. Meanwhile, some bone morphometric parameters, trabecular bone number (Tb.N), trabecular bone volume fraction (BV/TV), trabecular bone thickness (Tb.Th) and cortical bone wall thickness (Ct.Th), were also increased by 8.20%, 118.18%, 32.99% and 19.10%, respectively. In addition, the alkaline phosphatase (ALP) levels in serum were significantly reduced after CAA-Ca treatment, while the blood calcium levels were increased. Mechanistically, CAA-Ca down-regulated the levels of receptor activator of nuclear factor-kappa B (RANK) and receptor activator of nuclear factor-kappa B ligand (RANKL), and up-regulated osteoprotegerin (OPG) levels in osteoclasts, inhibiting bone resorption and bone loss. Meanwhile, CAA-Ca treatment raised beta-catenin levels and lowered Dickkopf1 (DKK1) levels in the Wnt signaling pathway of osteoblasts, which can promote calcium absorption and bone formation. CONCLUSION The results suggested that CAA-Ca promoted bone formation, inhibited bone resorption and improved bone microstructure. Therefore, this study contributes to the potential application of CAA-Ca as a functional food resource in the treatment of postmenopausal osteoporosis. (c) 2021 Society of Chemical Industry

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available